Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;26(2):175-186.
doi: 10.1007/s11154-024-09940-7. Epub 2025 Jan 2.

The radiologic spectrum of neuroendocrine tumors in emergent care

Affiliations
Review

The radiologic spectrum of neuroendocrine tumors in emergent care

Asutosh Sahu et al. Rev Endocr Metab Disord. 2025 Apr.

Abstract

Neuroendocrine tumors (NETs) are a diverse group of neoplasms whose prevalence is increasing globally, primarily due to advancements in diagnostic techniques. NETs arise from cells of the diffuse endocrine system and can occur in various locations, with the gastrointestinal tract being the most common. Their diverse clinical presentations, which range from asymptomatic to severe hormone-induced syndromes, pose significant diagnostic challenges. In emergency care, prompt recognition and management of complications such as bowel obstruction, ischemic events, hormonal crises, and metastases are critical. This review discusses the radiologic spectrum of NETs in emergent care, emphasizing the role of imaging in timely diagnosis and intervention.

Keywords: Emergency; Imaging; Neuroendocrine tumors.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Zheng Z, Chen C, Jiang L, et al. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: a population-based study. Cancer Med. 2019;8(17):7288–98. - PubMed - PMC - DOI
    1. Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115–54. - PubMed - DOI
    1. Yao JC, Hassan M, Phan A, et al. One hundred years after Carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72. - PubMed - DOI
    1. Lamberti G, La Salvia A. Neuroendocrine tumors: challenges and Future perspectives. J Clin Med. 2022;11(15):4351. - PubMed - PMC - DOI
    1. Rossi RE, Massironi S. The increasing incidence of neuroendocrine neoplasms worldwide: current knowledge and open issues. J Clin Med. 2022;11(13):3794. - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources